Drug Development/R&D
New medicines lead to improved patient outcomes and societal benefits, but R&D is a long and costly process. Ongoing health economics research aims to find the right balance between incentivising manufacturers to innovate and ensuring affordable access for health systems.
Economic Evaluation and Develop Medicines in the Development of Medicines
1 April 1988
In most countries the resources available for health care are increasingly stretched in the face of the competing demands for their use. Therefore health care policy…
Crisis in Research
1 April 1986
In 1983 almost £6.6 billion was spent on research and development in the United Kingdom. This sum was five times that recorded in 1972 and even…
Pharmaceutical Innovation: Recent Trends, Future Prospects
1 October 1983
Therapeutic progress in recent decades has made a major contribution to reductions in mortality and has extended control to the symptoms of many chronic diseases. Thus…
Economic Aspects of the Development of New Medicines
1 January 1981
A lecture, on the economics of developing new drugs, particularly in relation to whether this should be a national or private enterprise. I have chosen to…
Health Research in England: Topic for Debate
1 January 1981
This paper is derived from the proceedings of an Office of Health Economics Study Day, held at the Royal College of Obstetricians and Gynaecology on 11…
Health Care Research Expenditure
1 June 1978
In the financial year 1976-77 over £220 million was spent on health care research in the United Kingdom. Taking account of recent expenditure growth and making…
Innovation in Industry: a Factor for Growth
1 July 1969
Over the past few years there has been a growing concern with Britain’s record of industrial innovation based upon technology. This stems from two factors. Firstly,…
Pharmaceutical Research: the Case for Growth in Britain
1 July 1967
ONE of the problems in Britain today is that too little of its academic research is associated with successful innovation in industry. The result is that…
Science, Industry in the State
7 January 1965
Based on a series of six lectures discussing some of the special considerations which arise when a science based industry has the government as a major…